Cochrane: honey rated better for children’s cough than some OTC preps or placebo

Cochrane: honey rated better for children’s cough than some OTC preps or placebo

April 16 2018 Honey appears likely to help children’s cough more than diphenhydramine, a...

OTC Viagra Connect availability to widen following launch via Boots

OTC Viagra Connect availability to widen following launch via Boots

April 11 2018 Viagra Connect should be available from most pharmacies at the end of this week,...

MHRA issues warning over flammability of headlice treatments

MHRA issues warning over flammability of headlice treatments

March 9 2018 Pharmacists have been asked to tell customers about the risk of fire when discussing...

OTC industry proposes maximum level for vitamin D in food supplements

OTC industry proposes maximum level for vitamin D in food supplements

March 6 2018 Food supplement manufacturers are proposing to set the maximum dose of vitamin D at...

Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

March 5 2018 There is no evidence to show any specific nutrient or food supplement affects the...

  • Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Cochrane: honey rated better for children’s cough than some OTC preps or placebo

    Monday, 16 April 2018 09:13
  • OTC Viagra Connect availability to widen following launch via Boots

    OTC Viagra Connect availability to widen following launch via Boots

    Wednesday, 11 April 2018 12:52
  • MHRA issues warning over flammability of headlice treatments

    MHRA issues warning over flammability of headlice treatments

    Friday, 09 March 2018 16:15
  • OTC industry proposes maximum level for vitamin D in food supplements

    OTC industry proposes maximum level for vitamin D in food supplements

    Tuesday, 06 March 2018 12:24
  • Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

    Specific nutrients or food supplements do not reduce dementia risk, based on current evidence

    Monday, 05 March 2018 12:11

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a psoriasis hand imageSeptember 20 2017

Leo Pharma has announced it will not now launch an over-the-counter version of Dovonex Psoriasis Ointment, despite recently receiving authorisation to do so.

 Last month, the medicines regulator, the MHRA, announced that it had approved the application for a Pharmacy only product. Dovonex Psoriasis Ointment containing calcipotriol 50microgrammes/g was to be available in a 60g tube for adults “with mild to moderate plaque psoriasis which has been previously diagnosed by a doctor.”

However, Leo Pharma UK and Ireland has now announced that it will not launch the OTC product in the UK. The original Prescription Only Medicine version will remain available for the topical treatment of plaque psoriasis (psoriasis vulgaris) amenable to topical therapy.

Explaining its decision, the company said: “The reason for this new approach is that our commercial and strategic priorities have evolved with the introduction of our new strategy towards 2025.

“Whilst our legacy is firmly grounded in topical treatments, and we continue to invest in our successful topical therapy portfolio, our focus is moving towards strengthening our capabilities and priorities around our new emerging dermatology systemic portfolio. This will help us with our ultimate mission to help people achieve healthy skin by expanding our treatment offering to further meet the needs of people with skin diseases.”

Link:
Leo Pharma UK  
Today’s Pharmacist coverage of MHRA announcement (August 22 2017)

OTC News

April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...
April 23 2018 Buprenorphine has been found to have lower rates of overdose death than methadone when used in opioid substitute therapy. The impact was particularly seen in the first four weeks of...